Checkmate Pharmaceuticals, Inc.
CMPI
|
$10.5
0.0%
|
Health Technology
(0.0% 1d) (0.2% 1m) (0.0% 1y) (0.2% 2d) (0.1% 3d) (0.0% 7d) (-49.8% volume)
Earnings Calendar: 2022-08-11
Market Cap:
http://www.checkmatepharma.com
Sec Filling | Patents | 22 employees
Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. It specializes in the field of CpG oligonucleotides. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.
cancer
add to watch list Paper trade email alert is off
Press-releases
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Published: 2024-02-02 (Crawled : 12:00) - globenewswire.com
TSVT | $4.65 2.88% 3.21% 0
|
|
| O: -1.16%
H: 9.94%
C: 2.34%
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
REGN | News | $910.82 1.18% 21K
|
Health Technology
|
| O: 1.4%
H: 0.28%
C: -2.68%
ALNY | $147.93 1.47% 13K
|
Health Technology
|
| O: -1.23%
H: 1.0%
C: 0.17%
year financial results
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Published: 2023-02-03 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 0
|
Health Technology
|
| O: -5.75%
H: 0.0%
C: 0.0%
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: -4.01%
H: 0.0%
C: 0.0%
REGN | News | $910.82 1.18% 21K
|
Health Technology
|
| O: 1.77%
H: 3.33%
C: 2.44%
CTMX | $1.69 1.2% 14K
|
Health Technology
|
| O: 0.39%
H: 4.23%
C: 1.92%
ACET | News | $2.08 4.0% 420K
|
Health Technology
|
| O: -1.63%
H: 1.98%
C: -3.52%
year financial results
Regeneron Reports Second Quarter 2022 Financial and Operating Results
Published: 2022-08-03 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 0
|
Health Technology
|
| O: -2.6%
H: 0.0%
C: -0.76%
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: -0.17%
H: 0.12%
C: -1.29%
REGN | News | $910.82 1.18% 21K
|
Health Technology
|
| O: 4.36%
H: 3.91%
C: 1.46%
results
Regeneron Completes Purchase of Sanofi's Stake in Libtayo® (cemiplimab)
Published: 2022-07-01 (Crawled : 12:00) - prnewswire.com
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
REGN | News | $910.82 1.18% 21K
|
Health Technology
|
| O: -0.57%
H: 1.57%
C: 1.3%
libtayo
Kuros Biosciences: Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers a $5 Million Milestone Payment
Published: 2022-06-02 (Crawled : 06:00) - globenewswire.com
XOMA | $25.82 18
|
Health Technology
|
| O: -8.73%
H: 5.95%
C: 4.37%
REGN | News | $910.82 1.18% 21K
|
Health Technology
|
| O: -2.18%
H: 0.0%
C: -3.71%
acquisition payment milestone
Regeneron Completes Acquisition of Checkmate Pharmaceuticals
Published: 2022-05-31 (Crawled : 13:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 0
|
Health Technology
|
| O: -2.5%
H: 0.54%
C: 0.54%
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: -3.21%
H: 0.0%
C: 0.0%
REGN | News | $910.82 1.18% 21K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -4.05%
acquisition
Regeneron Reports First Quarter 2022 Financial and Operating Results
Published: 2022-05-04 (Crawled : 11:00) - prnewswire.com
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: -3.68%
H: 0.0%
C: 0.0%
REGN | News | $910.82 1.18% 21K
|
Health Technology
|
| O: 1.63%
H: 0.0%
C: 0.0%
NTLA | $22.595 3.5% 66K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
CMPI | $10.5 0.0%
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.19%
ACET | News | $2.08 4.0% 420K
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
results
Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-29 (Crawled : 21:00) - globenewswire.com
CMPI | $10.5 0.0%
|
Health Technology
|
| O: -1.25%
H: 2.52%
C: 1.58%
results
Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
CMPI | $10.5 0.0%
|
Health Technology
|
| O: 6.56%
H: 0.29%
C: 0.0%
america als research cancer
Checkmate Pharmaceuticals Welcomes Industry Leader Jon Wigginton, M.D. to its Board of Directors
Published: 2022-01-31 (Crawled : 22:00) - biospace.com/
CMPI | $10.5 0.0%
|
Health Technology
|
| O: 0.91%
H: 10.41%
C: 10.41%
als
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M
|
AGBA | $2.615 109.2% 14M
|
Finance
EDBL | News | $7.37 96.01% 650K
|
PALI | $7.64 54.97% 14M
|
Manufacturing
OPRT | News | $3.19 41.78% 3M
|
Finance
PEGY | $0.0629 37.34% 110M
|
Manufacturing
MLEC | $1.87 33.57% 1.6M
|
n/a
ATGL | $3.66 27.97% 150K
|
KULR | $0.5446 22.0% 6.8M
|
Manufacturing
MDIA 4 | $2.205 21.15% 150K
|
Consumer Services
Last 48 Hours Insiders Buying
ETST P 79000 | $0.065 18.18% 0
|
Manufacturing
|
11:30
MCFT P 26039 | $21.555 0.26% 17K
|
Consumer Durables
|
00:00
YORW P 29 | $35.42 1.5K
|
Utilities
|
19:01
VUZI P 14500 | $1.35 11.57% 10.37% 5.2K
|
Electronic Technology
|
17:00
BANF P 256 | $91.28 2.24% 2.18% 0
|
Finance
|
15:30
RMCF | $3.57 43
|
Consumer Non-Durables
|
20:10